Annual Cash & Cash Equivalents
$216.68 M
-$62.72 M-22.45%
31 December 2023
Summary:
HilleVax annual cash & cash equivalents is currently $216.68 million, with the most recent change of -$62.72 million (-22.45%) on 31 December 2023. During the last 3 years, it has risen by +$92.11 million (+73.95%). HLVX annual cash & cash equivalents is now -22.45% below its all-time high of $279.40 million, reached on 31 December 2022.HLVX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$103.76 M
-$4.68 M-4.32%
30 September 2024
Summary:
HilleVax quarterly cash and cash equivalents is currently $103.76 million, with the most recent change of -$4.68 million (-4.32%) on 30 September 2024. Over the past year, it has dropped by -$112.91 million (-52.11%). HLVX quarterly cash and cash equivalents is now -67.02% below its all-time high of $314.61 million, reached on 30 June 2022.HLVX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HLVX Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -52.1% |
| 3 y3 years | +74.0% | -16.7% |
| 5 y5 years | - | - |
HLVX Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -22.4% | +74.0% | -67.0% | at low |
| 5 y | 5 years | -22.4% | >+9999.0% | -67.0% | at low |
| alltime | all time | -22.4% | >+9999.0% | -67.0% | at low |
HilleVax Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $103.76 M(-4.3%) |
| June 2024 | - | $108.44 M(-23.1%) |
| Mar 2024 | - | $141.08 M(-34.9%) |
| Dec 2023 | $216.68 M(-22.4%) | $216.68 M(+3.9%) |
| Sept 2023 | - | $208.50 M(+31.7%) |
| June 2023 | - | $158.38 M(-39.2%) |
| Mar 2023 | - | $260.54 M(-6.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $279.40 M(+124.3%) | $279.40 M(-4.3%) |
| Sept 2022 | - | $292.06 M(-7.2%) |
| June 2022 | - | $314.61 M(+182.8%) |
| Mar 2022 | - | $111.25 M(-10.7%) |
| Dec 2021 | $124.57 M(>+9900.0%) | - |
| Dec 2021 | - | $124.57 M |
| Dec 2020 | $457.00 K | - |
FAQ
- What is HilleVax annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for HilleVax?
- What is HilleVax quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for HilleVax?
- What is HilleVax quarterly cash and cash equivalents year-on-year change?
What is HilleVax annual cash & cash equivalents?
The current annual cash & cash equivalents of HLVX is $216.68 M
What is the all time high annual cash & cash equivalents for HilleVax?
HilleVax all-time high annual cash & cash equivalents is $279.40 M
What is HilleVax quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of HLVX is $103.76 M
What is the all time high quarterly cash and cash equivalents for HilleVax?
HilleVax all-time high quarterly cash and cash equivalents is $314.61 M
What is HilleVax quarterly cash and cash equivalents year-on-year change?
Over the past year, HLVX quarterly cash and cash equivalents has changed by -$112.91 M (-52.11%)